1. Home
  2. PRME vs MBUU Comparison

PRME vs MBUU Comparison

Compare PRME & MBUU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prime Medicine Inc.

PRME

Prime Medicine Inc.

HOLD

Current Price

$3.07

Market Cap

536.4M

Sector

Health Care

ML Signal

HOLD

Logo Malibu Boats Inc.

MBUU

Malibu Boats Inc.

HOLD

Current Price

$28.05

Market Cap

541.4M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRME
MBUU
Founded
2019
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Marine Transportation
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
536.4M
541.4M
IPO Year
2022
2013

Fundamental Metrics

Financial Performance
Metric
PRME
MBUU
Price
$3.07
$28.05
Analyst Decision
Buy
Hold
Analyst Count
6
5
Target Price
$7.56
$32.20
AVG Volume (30 Days)
4.4M
302.1K
Earning Date
05-08-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
18.18
127.74
EPS
N/A
N/A
Revenue
$4,632,000.00
$807,561,000.00
Revenue This Year
$7.06
$2.14
Revenue Next Year
$47.01
$12.78
P/E Ratio
N/A
N/A
Revenue Growth
55.28
N/A
52 Week Low
$2.67
$23.84
52 Week High
$6.94
$39.65

Technical Indicators

Market Signals
Indicator
PRME
MBUU
Relative Strength Index (RSI) 41.07 55.83
Support Level $2.68 $28.10
Resistance Level $3.82 $29.57
Average True Range (ATR) 0.32 1.29
MACD -0.11 0.24
Stochastic Oscillator 0.57 73.33

Price Performance

Historical Comparison
PRME
MBUU

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its program, PM577 for Wilson Disease, is designed to initially correct the H1069Q mutation in the ATP7B gene and is supported by preclinical data showing targeted correction and restoration of copper homeostasis in animal models. In addition, PM647 is being developed for alpha-1 antitrypsin deficiency, or AATD, another liver targeted disease with substantial unmet need.

About MBUU Malibu Boats Inc.

Malibu Boats is a designer and manufacturer of power boats in the United States. It is a market leader in performance sport boats, sold under its Malibu and Axis brands. It acquired Cobalt Boats, a producer of sterndrive boats, in 2017, and Pursuit Boats, which makes high-end offshore and outboard motorboats, in 2018. In 2021, it purchased Maverick Boat Group, a seller of flat fishing boats, with exposure to bay, dual console, and center console boats. Most recently, in 2026, it tied up with Saxdor Yachts, focused on adventure dayboats. Malibu has also expanded into boat trailers and accessories, and in 2020, began producing its own engines for its performance sport boats.

Share on Social Networks: